Eli Lilly to Invest over $6bn on the New Huntsville Facility

Eli Lilly investment of over $6bn on the new Huntsville facility is single-largest in Alabama and will produce small molecule synthetic and peptide medicines.

Thermo Fisher to Expand Bioprocess Design Centers in Asia

Thermo Fisher has decided to expand its Bioprocess Design Centers in Asia hence further deepening its priorities within the advancing biopharmaceutical sector.

EU Pharmaceutical Legislation to be Reformed After 2 Decades

Reform of EU pharmaceutical legislation introduces exclusivity model, updated orphan drug rules, AMR incentives and more measures to improve medicine access.

Bora – Corealis Collaborate for Oral Solid Dose Development

A strategic alliance has been formed between Bora Pharmaceuticals and Corealis Pharma to offer end-to-end oral solid dose development and manufacturing.

India Outpaces Global Average With 2026 Medical Trend at 11.5 Percent: Aon Reports

India’s medical trend rate will reach 11.5% in 2026, reflecting moderated growth driven by chronic conditions, utilisation patterns and employer initiatives.